Page last updated: 2024-10-25

dantrolene and Diabetes Mellitus, Type 1

dantrolene has been researched along with Diabetes Mellitus, Type 1 in 1 studies

Dantrolene: Skeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber. It is used in spasticity and other neuromuscular abnormalities. Although the mechanism of action is probably not central, dantrolene is usually grouped with the central muscle relaxants.
dantrolene : The hydrazone resulting from the formal condensation of 5-(4-nitrophenyl)furfural with 1-aminohydantoin. A ryanodine receptor antagonist used for the relief of chronic severe spasticity and malignant hyperthermia.

Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.

Research Excerpts

ExcerptRelevanceReference
" A diagnosis of neuroleptic malignant syndrome was made, and the patient was given dantrolene with prompt and complete resolution of all signs and symptoms."7.68Neuroleptic malignant syndrome induced by domperidone. ( Chan, W; Sachar, DB; Spirt, MJ; Thieberg, M, 1992)
" A diagnosis of neuroleptic malignant syndrome was made, and the patient was given dantrolene with prompt and complete resolution of all signs and symptoms."3.68Neuroleptic malignant syndrome induced by domperidone. ( Chan, W; Sachar, DB; Spirt, MJ; Thieberg, M, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Spirt, MJ1
Chan, W1
Thieberg, M1
Sachar, DB1

Other Studies

1 other study available for dantrolene and Diabetes Mellitus, Type 1

ArticleYear
Neuroleptic malignant syndrome induced by domperidone.
    Digestive diseases and sciences, 1992, Volume: 37, Issue:6

    Topics: Dantrolene; Diabetes Mellitus, Type 1; Domperidone; Female; Humans; Malignant Hyperthermia; Middle A

1992